How Much Did Maolac Raise?
Funding & Key Investors

Maolac has secured $3.2M in total capital, with its most recent funding round bringing in $3.2M through a major strategic investment. This significant backing underscores the company's progress in the advanced biofunctional proteins sector.

What is Maolac?

Maolac
ManufacturingFood & BeverageHealth & Nutrition Products

Maolac specializes in developing advanced colostrum-based biofunctional proteins, drawing inspiration from human breast milk to deliver clinically tested health benefits. Their product line, which includes Super Colostrum and Maolactin, is engineered for superior absorption and targets key wellness areas such as gut health, muscle recovery, and general well-being. The company aims to serve a diverse clientele, including athletes, seniors, and health-conscious consumers seeking effective nutritional solutions. Maolac's innovative, heat-stable formulations are versatile, enabling their integration into various applications like gummies and powders, positioning them as a key innovator in the functional food ingredients market.

How much funding has Maolac raised?

Maolac has raised a total of $3.2M across 1 funding round:

2022

Angel/Seed

$3.2M

Angel/Seed (2022): $3.2M with participation from The Food Tech Lab, The Kitchen FoodTech H, and OurCrowd

Key Investors in Maolac

The Food Tech Lab

The Food Tech Lab is an entity focused on advancing food technology innovations, likely providing strategic and operational support to early-stage companies in the sector.

The Kitchen FoodTech H

The Kitchen FoodTech H appears to be a venture capital firm or incubator specializing in the food technology space, offering investment and expertise to promising startups.

OurCrowd

OurCrowd is a global investment platform that enables accredited investors and institutions to invest in startups and venture capital funds, with a focus on technology and innovation.

What's next for Maolac?

The recent major strategic investment signals a pivotal growth phase for Maolac, likely enabling the company to scale its operations, expand its product development pipeline, and broaden its market reach. This capital infusion is expected to accelerate the commercialization of its colostrum-based biofunctional proteins, further solidifying its position in the competitive health and wellness industry. The company's focus on clinically tested, highly absorbable ingredients suggests a strategy centered on scientific validation and premium product offerings, aiming to capture a significant share of the growing market for specialized nutritional supplements.

See full Maolac company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Household GoodsManufacturingPet Products
Industrial Machinery & EquipmentManufacturing
Automotive PartsManufacturingElectronics
ManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding Maolac Financial Insights

What are the most recent funding rounds that Maolac has completed, and what were the funding rounds?
Maolac has recently completed 1 funding rounds: Angel/Seed on Jul 6, 2022.
What is the total amount of funding Maolac has raised to date?
Maolac has raised a total of $3.2M in funding to date.
How many funding rounds has Maolac completed?
Maolac has completed 1 funding rounds.
How much funding did Maolac raise in its most recent funding round?
Maolac raised $3.2M in its most recent funding round.
Who are the lead investors in Maolac's latest funding round?
The lead investor in Maolac's latest funding round was The Food Tech Lab. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Maolac's history?
The largest funding round in Maolac's history was $3.2M.
See more information about Maolac